SEC 13F Intelligence

Jones Financial Companies Lllp / ABT

Jones Financial Companies Lllp’s Abbott Laboratories Position

Does Jones Financial Companies Lllp own Abbott Laboratories (ABT)? Yes — 1.50M shares worth $156M (+0.07% of its 13F portfolio) as of Q1 2026, up from 505.9K shares the prior filed quarter.

Position Value
$156M
Q1 2026
Shares
1.50M
% of Portfolio
+0.07%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $11MQ4 ’18Q1 ’19: $13MQ2 ’19: $13MQ3 ’19: $13MQ4 ’19: $14MQ4 ’19Q1 ’20: $13MQ2 ’20: $15MQ3 ’20: $17MQ4 ’20: $17MQ4 ’20Q1 ’21: $19MQ2 ’21: $18MQ3 ’21: $18MQ4 ’21: $22MQ4 ’21Q1 ’22: $18MQ2 ’22: $17MQ3 ’22: $15MQ4 ’22: $17MQ4 ’22Q1 ’23: $16MQ2 ’23: $20MQ3 ’23: $17MQ4 ’23: $20MQ4 ’23Q1 ’24: $22MQ2 ’24: $26MQ3 ’24: $30MQ4 ’24: $36MQ4 ’24Q1 ’25: $46MQ2 ’25: $56MQ3 ’25: $64MQ4 ’25: $63MQ4 ’25Q1 ’26: $156Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.50M$156M+0.07%
Q4 2025505.9K$63M+0.04%
Q3 2025475.2K$64M+0.04%
Q2 2025413.6K$56M+0.04%
Q1 2025348.9K$46M+0.04%
Q4 2024315.8K$36M+0.03%
Q3 2024266.7K$30M+0.03%
Q2 2024250.2K$26M+0.03%
Q1 2024190.6K$22M+0.03%
Q4 2023183.2K$20M+0.03%
Q3 2023179.1K$17M+0.03%
Q2 2023180.9K$20M+0.03%
Q1 2023154.1K$16M+0.03%
Q4 2022157.2K$17M+0.03%
Q3 2022154.5K$15M+0.03%
Q2 2022152.1K$17M+0.03%
Q1 2022156.2K$18M+0.03%
Q4 2021155.9K$22M+0.03%
Q3 2021156.0K$18M+0.03%
Q2 2021157.3K$18M+0.03%
Q1 2021158.2K$19M+0.03%
Q4 2020155.8K$17M+0.03%
Q3 2020153.5K$17M+0.03%
Q2 2020160.4K$15M+0.03%
Q1 2020170.1K$13M+0.03%
Q4 2019158.6K$14M+0.03%
Q3 2019157.7K$13M+0.03%
Q2 2019159.3K$13M+0.03%
Q1 2019156.9K$13M+0.03%
Q4 2018157.8K$11M+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jones Financial Companies Lllp’s full portfolio or all institutional holders of ABT.